These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25060202)

  • 41. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
    Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
    J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognosis and outcome of relapsed acute lymphoblastic leukemia: a Hong Kong Pediatric Hematology and Oncology Study Group report.
    Leung AW; Vincent L; Chiang AK; Lee AC; Cheng FW; Cheuk DK; Luk CW; Ling SC; Li CK
    Pediatr Blood Cancer; 2012 Sep; 59(3):454-60. PubMed ID: 22610685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified "New York" protocols (1987-2003)].
    Kwiecińska K; Balwierz W; Moryl-Bujakowska A; Wachowiak J; Derwich K; Matysiak M; Pawelec K; Chybicka A; Dobaczewski G; Kowalczyk JR; Wiśniewska-Slusarz H; Sońta-Jakimczyk D; Szczepański T; Tomaszewska R; Wysocki M; Styczyński J; Balcerska A; Płoszyńska A
    Przegl Lek; 2010; 67(6):350-4. PubMed ID: 21344760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
    Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of therapeutic effectiveness of Nanfang ALL 99 protocol in childhood acute lymphoblastic leukemia patients].
    Wu XD; Li CF; He YL; Yang M; Zhang YM; Feng XQ; Teng ZL; Sun SM; Qian XH
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):890-3. PubMed ID: 16412348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China.
    Wei W; Chen X; Zou Y; Chang L; An W; Wan Y; Liu T; Yang W; Chen Y; Guo Y; Zhu X
    BMC Pediatr; 2015 Jul; 15():80. PubMed ID: 26174476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children.
    Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM
    J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Could intensified treatment in childhood acute lymphoblastic leukemia improve outcome independently of risk factors?
    Tzortzatou-Stathopoulou F; Moschovi MA; Papadopoulou AL; Barbounaki IG; Lambrou GI; Balafouta M; Syriopoulou V
    Eur J Haematol; 2005 Nov; 75(5):361-9. PubMed ID: 16191084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.
    Saarinen-Pihkala UM; Gustafsson G; Carlsen N; Flaegstad T; Forestier E; Glomstein A; Kristinsson J; Lanning M; Schroeder H; Mellander L;
    Pediatr Blood Cancer; 2004 Jan; 42(1):8-23. PubMed ID: 14752789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].
    Badowska W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1001-7. PubMed ID: 19531816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
    Derwich K; Kaczmarek-Kanold M; Wachowiak J; Balcerska A; Balwierz W; Chybicka A; Kowalczyk JR; Matysiak M; Sońta-Jakimczyk D; Wysocki M; Chełmecka-Hanuszewicz L; Jackowska T; Kołtan A; Cwiklińska M; Odój T; Płoszyńska A; Steczowicz M; Wojciechowska V; Wójtowicz A
    Przegl Lek; 2004; 61 Suppl 2():49-52. PubMed ID: 15686046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
    Hasegawa D; Manabe A; Ohara A; Kikuchi A; Koh K; Kiyokawa N; Fukushima T; Ishida Y; Saito T; Hanada R; Tsuchida M;
    Pediatr Blood Cancer; 2012 Jan; 58(1):23-30. PubMed ID: 21254378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
    Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
    Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.
    Clarke M; Gaynon P; Hann I; Harrison G; Masera G; Peto R; Richards S;
    J Clin Oncol; 2003 May; 21(9):1798-809. PubMed ID: 12721257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy and prognosis analysis in 188 children with acute lymphoblastic leukemia of China].
    Yang MH; Jia WG; Cao LZ; He YL; Liao N; Chen GL; Luo JM; Xu WQ; Yang J
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):498-501. PubMed ID: 19099804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries.
    Hjalgrim LL; Rostgaard K; Schmiegelow K; Söderhäll S; Kolmannskog S; Vettenranta K; Kristinsson J; Clausen N; Melbye M; Hjalgrim H; Gustafsson G
    J Natl Cancer Inst; 2003 Oct; 95(20):1539-44. PubMed ID: 14559876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.